Literature DB >> 19210906

Aspirin sensitivity and desensitization for asthma and sinusitis.

Donald D Stevenson1.   

Abstract

NSAIDs-including aspirin (ASA)-that inhibit cyclooxygenase (COX)-1 induce nonallergic hypersensitivity reactions consisting of attacks of rhinitis and asthma. Such reactions occur exclusively in a subset of asthmatic patients who also have underlying nasal polyps and chronic hyperplastic eosinophilic sinusitis. We now refer to their underlying inflammatory disease of the entire respiratory tract as aspirin-exacerbated respiratory disease. This review focuses on descriptions of these patients; methods available to diagnose ASA-exacerbated respiratory disease; the unique ability of all NSAIDs that inhibit COX-1 to cross-react with ASA; lack of cross-reactivity with selective COX-2 inhibitors; an update on pathogenesis; and current thoughts about treatment, including ASA desensitization and daily ingestion of ASA itself.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19210906     DOI: 10.1007/s11882-009-0023-4

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  47 in total

1.  Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib.

Authors:  Pär Gyllfors; Grazyna Bochenek; John Overholt; Diane Drupka; Maria Kumlin; James Sheller; Ewa Nizankowska; Peter C Isakson; Filip Mejza; James B Lefkowith; Sven-Erik Dahlén; Andrew Szczeklik; John J Murray; Barbro Dahlén
Journal:  J Allergy Clin Immunol       Date:  2003-05       Impact factor: 10.793

2.  Outcome analysis of endoscopic sinus surgery for chronic sinusitis in patients having Samter's triad.

Authors:  Y G Amar; S Frenkiel; S E Sobol
Journal:  J Otolaryngol       Date:  2000-02

3.  Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.

Authors:  B Dahlén; E Nizankowska; A Szczeklik; O Zetterström; G Bochenek; M Kumlin; L Mastalerz; G Pinis; L J Swanson; T I Boodhoo; S Wright; L M Dubé; S E Dahlén
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

4.  Intolerance to aspirin. Clinical studies and consideration of its pathogenesis.

Authors:  M Samter; R F Beers
Journal:  Ann Intern Med       Date:  1968-05       Impact factor: 25.391

5.  Salsalate cross-sensitivity in aspirin-sensitive patients with asthma.

Authors:  D D Stevenson; A J Hougham; P J Schrank; M B Goldlust; R R Wilson
Journal:  J Allergy Clin Immunol       Date:  1990-11       Impact factor: 10.793

6.  The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions.

Authors:  M P Berges-Gimeno; R A Simon; D D Stevenson
Journal:  Clin Exp Allergy       Date:  2002-10       Impact factor: 5.018

7.  Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma.

Authors:  E Nizankowska; A Bestyńska-Krypel; A Cmiel; A Szczeklik
Journal:  Eur Respir J       Date:  2000-05       Impact factor: 16.671

Review 8.  The broken balance in aspirin hypersensitivity.

Authors:  Andrzej Szczeklik; Marek Sanak
Journal:  Eur J Pharmacol       Date:  2006-02-07       Impact factor: 4.432

9.  Nasal secretions in response to acetylsalicylic acid.

Authors:  M L Kowalski; M Sliwinska-Kowalska; Y Igarashi; M V White; B Wojciechowska; P Brayton; H Kaulbach; J Rozniecki; M A Kaliner
Journal:  J Allergy Clin Immunol       Date:  1993-02       Impact factor: 10.793

10.  Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma.

Authors:  P Sestini; L Armetti; G Gambaro; M G Pieroni; R M Refini; A Sala; A Vaghi; G C Folco; S Bianco; M Robuschi
Journal:  Am J Respir Crit Care Med       Date:  1996-02       Impact factor: 21.405

View more
  21 in total

1.  [Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; R Weber; K Hörmann
Journal:  HNO       Date:  2012-02       Impact factor: 1.284

2.  Increased expression of CC chemokine ligand 18 in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Sarah Peterson; Julie A Poposki; Deepti R Nagarkar; Regina T Chustz; Anju T Peters; Lydia A Suh; Roderick Carter; James Norton; Kathleen E Harris; Leslie C Grammer; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Robert P Schleimer; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2011-09-23       Impact factor: 10.793

Review 3.  [Aspirin-Intolerance-Syndrom : a common and interdisciplinary disease].

Authors:  C Umbreit; J C Virchow; C Thorn; K Hörmann; L Klimek; O Pfaar
Journal:  Internist (Berl)       Date:  2010-09       Impact factor: 0.743

Review 4.  Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).

Authors:  Ronald A Simon; Kristen M Dazy; Jeremy D Waldram
Journal:  Curr Allergy Asthma Rep       Date:  2015-03       Impact factor: 4.806

Review 5.  Update on Aspirin-Exacerbated Respiratory Disease.

Authors:  Katharine M Woessner
Journal:  Curr Allergy Asthma Rep       Date:  2017-01       Impact factor: 4.806

6.  [Adaptive desensitization for acetylsalicylic acid hypersensitivity: A success story?].

Authors:  G Mühlmeier; R Hausch; H Maier
Journal:  HNO       Date:  2015-10       Impact factor: 1.284

7.  [ASA-intolerance syndrome and persistent rhinosinusitis : Differential diagnosis and treatment].

Authors:  H Kirsche; L Klimek
Journal:  HNO       Date:  2015-05       Impact factor: 1.284

Review 8.  Rhinosinusitis and comorbidities.

Authors:  Matthew W Ryan; Edward G Brooks
Journal:  Curr Allergy Asthma Rep       Date:  2010-05       Impact factor: 4.806

Review 9.  Aspirin-exacerbated respiratory disease and current treatment modalities.

Authors:  Emine Güven Sakalar; Nuray Bayar Muluk; Murat Kar; Cemal Cingi
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-18       Impact factor: 2.503

Review 10.  The association of premorbid diseases with chronic rhinosinusitis with and without polyps.

Authors:  Kent Lam; Annemarie G Hirsch; Bruce K Tan
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2014-06       Impact factor: 2.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.